• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经心尖途径为 11 岁体动脉干患者输送 Sapien 瓣膜行经导管主动脉瓣置换术。

Transapical Delivery of a Sapien Valve for Transcatheter Aortic Valve Replacement in an 11-Year-Old Patient with Truncus Arteriosus.

机构信息

Division of Cardiology, Phoenix Children's Center for Heart Care, 1919 East Thomas Road, Phoenix, AZ, 85016, USA.

Division of Anesthesiology, Phoenix Children's Hospital, 1919 E Thomas Road, Phoenix, AZ, 85016, USA.

出版信息

Pediatr Cardiol. 2023 Oct;44(7):1629-1631. doi: 10.1007/s00246-023-03196-9. Epub 2023 Jun 7.

DOI:10.1007/s00246-023-03196-9
PMID:37285040
Abstract

Complex congenital heart defects may necessitate repeated surgical interventions throughout a patient's lifetime. Each subsequent procedure exposes patients to a greater cumulative risk, thus adding to the potential morbidity and mortality of the surgery. Transcatheter interventions can help mitigate the surgical risk for many defects and can delay or mitigate the need for surgery. This case report describes the rare use of a transapically delivered transcatheter aortic valve replacement (TAVR) therapy in a high-risk pediatric patient to postpone the need for surgery and potentially reduce the number of lifelong surgical interventions. The case highlights how transcatheter aortic valve therapies can be considered for non-standard, higher risk pediatric patients to postpone the need for surgical valve replacement and may serve as a paradigm shift in the care of complex patients with aortic valve pathology.

摘要

复杂的先天性心脏缺陷可能需要患者终身接受多次手术干预。每次后续手术都会使患者面临更大的累积风险,从而增加手术的潜在发病率和死亡率。经导管介入治疗可以帮助许多缺陷降低手术风险,并可以延迟或减轻手术的需要。本病例报告描述了一种罕见的经心尖入路的经导管主动脉瓣置换术(TAVR)治疗在高危儿科患者中的应用,以推迟手术的需要,并可能减少终生手术干预的次数。该病例强调了经导管主动脉瓣治疗如何可以考虑用于非标准、高风险的儿科患者,以推迟手术瓣膜置换的需要,并可能成为主动脉瓣病变复杂患者治疗的范式转变。

相似文献

1
Transapical Delivery of a Sapien Valve for Transcatheter Aortic Valve Replacement in an 11-Year-Old Patient with Truncus Arteriosus.经心尖途径为 11 岁体动脉干患者输送 Sapien 瓣膜行经导管主动脉瓣置换术。
Pediatr Cardiol. 2023 Oct;44(7):1629-1631. doi: 10.1007/s00246-023-03196-9. Epub 2023 Jun 7.
2
Application of transcatheter valves for aortic valve replacement in pediatric patients: A case series.经导管主动脉瓣置换术在儿科患者中的应用:病例系列。
Catheter Cardiovasc Interv. 2020 Feb;95(2):253-261. doi: 10.1002/ccd.28505. Epub 2019 Oct 14.
3
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.经导管主动脉瓣置换术与外科瓣膜置换术治疗中危患者的效果比较:倾向评分分析。
Lancet. 2016 May 28;387(10034):2218-25. doi: 10.1016/S0140-6736(16)30073-3. Epub 2016 Apr 3.
4
Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.经导管主动脉瓣置换术与外科主动脉瓣置换术在低危患者中的超声心动图结果:PARTNER 3 试验。
Circulation. 2020 May 12;141(19):1527-1537. doi: 10.1161/CIRCULATIONAHA.119.044574. Epub 2020 Apr 10.
5
Surgical Transcatheter Aortic Valve Replacement Explantation Technique.经导管主动脉瓣置换术的瓣叶取出技术。
Ann Thorac Surg. 2022 Dec;114(6):e471-e473. doi: 10.1016/j.athoracsur.2022.03.015. Epub 2022 Mar 25.
6
Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.经导管主动脉瓣置换术治疗严重症状性主动脉瓣狭窄患者的成本效益:从加拿大角度评估爱德华兹 SAPIEN 经导管心脏瓣膜与标准治疗及外科主动脉瓣置换术的比较。
J Thorac Cardiovasc Surg. 2013 Jul;146(1):52-60.e3. doi: 10.1016/j.jtcvs.2012.06.018. Epub 2012 Jul 11.
7
Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.经导管主动脉瓣置换术对中危外科手术风险严重主动脉瓣狭窄患者健康状况的影响:PARTNER S3i 试验结果。
JACC Cardiovasc Interv. 2018 Jun 25;11(12):1188-1198. doi: 10.1016/j.jcin.2018.02.032. Epub 2018 May 30.
8
Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.经股动脉途径行植入前瓣膜成形术与经心尖途径行导管主动脉瓣置换术时省略瓣膜成形术患者的装置成功率及30天临床结局
J Thorac Cardiovasc Surg. 2015 Nov;150(5):1111-7. doi: 10.1016/j.jtcvs.2015.07.050. Epub 2015 Jul 26.
9
Transcatheter Aortic Valve-in-Valve Replacement Instead of a 4th Sternotomy in a 21-Year-Old Woman with Aortic Homograft Failure.经导管主动脉瓣中瓣置换术替代21岁主动脉同种异体移植失败女性的第四次胸骨切开术
Tex Heart Inst J. 2016 Aug 1;43(4):334-7. doi: 10.14503/THIJ-15-5128. eCollection 2016 Aug.
10
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves.经导管主动脉瓣置换术治疗失败的经导管生物瓣。
JACC Cardiovasc Interv. 2022 Sep 26;15(18):1777-1793. doi: 10.1016/j.jcin.2022.07.035.

本文引用的文献

1
Dose approach matter? A meta-analysis of outcomes following transfemoral versus transapical transcatheter aortic valve replacement.经股动脉与经心尖途径行主动脉瓣置换术的结局:剂量相关吗?一项荟萃分析。
BMC Cardiovasc Disord. 2021 Jul 28;21(1):358. doi: 10.1186/s12872-021-02158-4.
2
Transcatheter and Surgical Aortic Valve Replacement in Patients With Previous Cardiac Surgery: A Meta-Analysis.既往心脏手术患者经导管与外科主动脉瓣置换术:一项荟萃分析。
Front Cardiovasc Med. 2021 Feb 10;7:612155. doi: 10.3389/fcvm.2020.612155. eCollection 2020.
3
Transcatheter Aortic Valve Replacement Programs: Clinical Outcomes and Developments.
经导管主动脉瓣置换计划:临床结果与进展。
J Am Heart Assoc. 2020 Apr 21;9(8):e015921. doi: 10.1161/JAHA.120.015921. Epub 2020 Apr 17.
4
Application of transcatheter valves for aortic valve replacement in pediatric patients: A case series.经导管主动脉瓣置换术在儿科患者中的应用:病例系列。
Catheter Cardiovasc Interv. 2020 Feb;95(2):253-261. doi: 10.1002/ccd.28505. Epub 2019 Oct 14.